(Q38067765)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

review article

1 reference

title

Chromatin landscape and endocrine response in breast cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Luca Magnani

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

author name string

Mylène Brunelle

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

Nicolas Gévry

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

publication date

1 December 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

page(s)

675-683

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

cites work

Global cancer statistics

1 reference

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

21 January 2018

1 reference

Chromosome-wide mapping of estrogen receptor binding reveals long-range regulation requiring the forkhead protein FoxA1

21 January 2018

1 reference

FoxA1 translates epigenetic signatures into enhancer-driven lineage-specific transcription

21 January 2018

1 reference

PBX1 genomic pioneer function drives ERα signaling underlying progression in breast cancer.

21 January 2018

1 reference

AP-2γ regulates oestrogen receptor-mediated long-range chromatin interaction and gene transcription

21 January 2018

1 reference

Transducin-like enhancer protein 1 mediates estrogen receptor binding and transcriptional activity in breast cancer cells

21 January 2018

1 reference

Cell-type selective chromatin remodeling defines the active subset of FOXA1-bound enhancers

21 January 2018

1 reference

Nucleosome dynamics define transcriptional enhancers

21 January 2018

1 reference

An oestrogen-receptor-α-bound human chromatin interactome

21 January 2018

1 reference

An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patients

21 January 2018

1 reference

Extensive promoter-centered chromatin interactions provide a topological basis for transcription regulation

21 January 2018

1 reference

Antiestrogens and their therapeutic applications in breast cancer and other diseases

21 January 2018

1 reference

Molecularly targeted endocrine therapies for breast cancer.

21 January 2018

1 reference

Tamoxifen: a most unlikely pioneering medicine

21 January 2018

1 reference

Advances in adjuvant endocrine therapy for postmenopausal women

21 January 2018

1 reference

Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer

21 January 2018

1 reference

Fulvestrant - a novel endocrine therapy for breast cancer.

21 January 2018

1 reference

Mechanisms of tamoxifen resistance

21 January 2018

1 reference

DNA methylation landscapes: provocative insights from epigenomics

21 January 2018

1 reference

The loss of estrogen and progesterone receptor gene expression in human breast cancer

21 January 2018

1 reference

Distinct mechanisms of loss of estrogen receptor alpha gene expression in human breast cancer: methylation of the gene and alteration of trans-acting factors.

21 January 2018

1 reference

Nonrandom distribution of aberrant promoter methylation of cancer-related genes in sporadic breast tumors

21 January 2018

1 reference

Estrogen receptor-alpha promoter methylation in sporadic basal-like breast cancer of Chinese women

21 January 2018

1 reference

Twist contributes to hormone resistance in breast cancer by downregulating estrogen receptor-α.

21 January 2018

1 reference

Specific inhibition of DNMT1 by antisense oligonucleotides induces re-expression of estrogen receptor-alpha (ER) in ER-negative human breast cancer cell lines.

21 January 2018

1 reference

Loss of estrogen receptor signaling triggers epigenetic silencing of downstream targets in breast cancer

21 January 2018

1 reference

Eliminating epigenetic barriers induces transient hormone-regulated gene expression in estrogen receptor negative breast cancer cells

21 January 2018

1 reference

To selectivity and beyond

21 January 2018

1 reference

Restoration of tamoxifen sensitivity in estrogen receptor-negative breast cancer cells: tamoxifen-bound reactivated ER recruits distinctive corepressor complexes

21 January 2018

1 reference

Diverse gene expression and DNA methylation profiles correlate with differential adaptation of breast cancer cells to the antiestrogens tamoxifen and fulvestrant

21 January 2018

1 reference

Biological determinants of endocrine resistance in breast cancer

21 January 2018

1 reference

Mechanisms of endocrine resistance in breast cancer

21 January 2018

1 reference

Growth factor stimulation induces a distinct ER(alpha) cistrome underlying breast cancer endocrine resistance

21 January 2018

1 reference

Crystal structure of the nucleosome core particle at 2.8 A resolution

21 January 2018

1 reference

Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome

21 January 2018

1 reference

Discovery and characterization of chromatin states for systematic annotation of the human genome

21 January 2018

1 reference

Mapping and analysis of chromatin state dynamics in nine human cell types

21 January 2018

1 reference

A unique chromatin signature uncovers early developmental enhancers in humans

21 January 2018

1 reference

A bivalent chromatin structure marks key developmental genes in embryonic stem cells

21 January 2018

1 reference

Histone modifications at human enhancers reflect global cell-type-specific gene expression

21 January 2018

1 reference

Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer

21 January 2018

1 reference

A chromatin-mediated reversible drug-tolerant state in cancer cell subpopulations

21 January 2018

1 reference

Epigenomic enhancer profiling defines a signature of colon cancer

21 January 2018

1 reference

New nomenclature for chromatin-modifying enzymes

21 January 2018

1 reference

Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma

21 January 2018

1 reference

Somatic mutations of the histone H3K27 demethylase gene UTX in human cancer

21 January 2018

1 reference

Epigenetic protein families: a new frontier for drug discovery

21 January 2018

1 reference

Functional activation of the estrogen receptor-α and aromatase by the HDAC inhibitor entinostat sensitizes ER-negative tumors to letrozole

21 January 2018

1 reference

Histone demethylation mediated by the nuclear amine oxidase homolog LSD1

21 January 2018

1 reference

Inhibition of the LSD1 (KDM1A) demethylase reactivates the all-trans-retinoic acid differentiation pathway in acute myeloid leukemia

21 January 2018

1 reference

Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology

21 January 2018

1 reference

Histone variants--ancient wrap artists of the epigenome

21 January 2018

1 reference

H3.3/H2A.Z double variant-containing nucleosomes mark 'nucleosome-free regions' of active promoters and other regulatory regions

21 January 2018

1 reference

Genomic analysis of estrogen cascade reveals histone variant H2A.Z associated with breast cancer progression

21 January 2018

1 reference

H2A.Z overexpression promotes cellular proliferation of breast cancer cells

21 January 2018

1 reference

Histone H2A.Z is essential for estrogen receptor signaling

21 January 2018

1 reference

Epigenetic switch involved in activation of pioneer factor FOXA1-dependent enhancers

21 January 2018

1 reference

Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA

21 January 2018

1 reference

Tamoxifen-stimulated growth of breast cancer due to p21 loss

21 January 2018

1 reference

p21 transcription is regulated by differential localization of histone H2A.Z.

21 January 2018

1 reference

Pioneer factors: directing transcriptional regulators within the chromatin environment

21 January 2018

1 reference

Pioneer transcription factors: establishing competence for gene expression

21 January 2018

1 reference

Pioneer factors in hormone-dependent cancers

21 January 2018

1 reference

FOXA1 is an independent prognostic marker for ER-positive breast cancer.

21 January 2018

1 reference

The NIH Roadmap Epigenomics Mapping Consortium

21 January 2018

1 reference

Moving AHEAD with an international human epigenome project.

21 January 2018

1 reference

A large fraction of extragenic RNA pol II transcription sites overlap enhancers

21 January 2018

1 reference

A long noncoding RNA maintains active chromatin to coordinate homeotic gene expression

21 January 2018

1 reference

Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis

21 January 2018

1 reference

Tamoxifen downregulation of miR-451 increases 14-3-3ζ and promotes breast cancer cell survival and endocrine resistance.

21 January 2018

1 reference

Aromatase inhibitor treatment of breast cancer cells increases the expression of let-7f, a microRNA targeting CYP19A1.

21 January 2018

1 reference

Comprehensive mapping of long-range interactions reveals folding principles of the human genome

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.2217/EPI.12.64

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23244312%20AND%20SRC:MED&resulttype=core&format=json

20 February 2020

1 reference